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A large-scale computational and genetic analysis study by Nilsson et al. (2009) has identified five genes
that coexpress with heme biosynthetic enzymes and are required for normal heme synthesis. Several are
implicated in iron-sulfur cluster biogenesis, and malfunction of these genes may repress heme synthesis
by activating the IRE/IRP posttranscriptional regulatory system.The eukaryotic heme biosynthetic path-
way consists of eight enzymes that func-
tion in mitochondria for the first and last
several steps or in the cytosol in the
intervening steps. After the first enzymatic
reaction and before the last, heme
intermediates must cross mitochondrial
membranes, and some of the transporters
involved in the complicated heme bio-
synthetic pathway remain unidentified,
including a mitochondrial heme exporter
proposed to function in erythroid cells.
Because heme intermediates must be
transported between the mitochondrial
and cytosolic compartments, it would
make sense for required transport and
regulatory proteins to be coordinately
regulated. To identify such factors, Nils-
son et al. used large-scale computational
screening to identify mitochondrial tran-
scripts that coexpress with the eight basic
hemebiosynthetic enzymes (Nilssonet al.,
2009 [this issue ofCell Metabolism]). They
identified five transcripts that warranted
further study, and they established that
morpholino knockdown of each of the
five transcripts impaired heme synthesis
in the zebrafish model system.
There are two major classes of cofac-
tors that utilize iron in cells: heme groups
and iron-sulfur (Fe-S) clusters. Heme
molecules consist of a porphyrin ring
with a single iron atombound in the center,
and Fe-S clusters are nonheme prosthetic
groups in which Fe atoms are bound to
inorganic sulfur (S) atoms and to S atoms
of cysteines from associated proteins
(Lill and Muhlenhoff, 2008; Rouault and
Tong, 2008). The presence of iron often
facilitates the ability of the prosthetic
group-bearing protein to accept or donate
a single electron, and fine-tuning of the
redox potentials of 12 Fe-S clusters and80 Cell Metabolism 10, August 6, 2009 ª20096 heme groups promotes electron trans-
port through mitochondrial respiratory
chain complexes I–IV.
Interestingly, there are two points in the
hemebiosynthetic pathwayofmammalian
and zebrafish erythroid cells at which
defects in the Fe-S cluster biogenesis
pathway can indirectly suppress heme
synthesis. The first intersection occurs in
the synthesis of the erythroid form of ami-
nolevulinic acid synthase, ALAS2, which
catalyzes the first step of heme biosyn-
thesis. The ALAS2 transcript contains
an iron-responsive element (IRE) in its
50UTR and is thus subject to regulation
by cytosolic iron regulatory proteins
(IRPs). The relationship between Fe-S
cluster biogenesis and heme synthesis
was first identified in zebrafish that were
deficient in glutaredoxin 5 (GLRX5), an
Fe-S cluster biogenesis protein. Genetic
experiments demonstrated that transla-
tion of ALAS2was repressed by activation
of iron regulatory protein 1 (IRP1) (Wingert
et al., 2005), a cytosolic regulatory protein
that binds to IREs when it lacks a cubane
Fe-S cluster at the active site (Rouault,
2006;Muckenthaler et al., 2008). A second
point of convergence between the heme
and Fe-S cluster biogenesis pathways
occurs in the final step of heme synthesis.
Ferrochelatase of higher eukaryotes, but
not yeast, contains a [2Fe-2S] cluster
that is thought to contribute to structural
stabilization of the enzyme (Wu et al.,
2001). Thus, defects that interfere with
Fe-S cluster biogenesis can potentially
interrupt heme synthesis by repressing
ALAS2 synthesis in erythroid cells or by
inactivating ferrochelatase.
Notably, two of the five genes that were
coexpressed with heme biosynthetic
enzymes, ISCA1 and C1orf69, have beenElsevier Inc.previously shown to be directly involved
in Fe-S cluster biogenesis (Gelling et al.,
2008), which is interesting because, even
though the heme and Fe-S cluster biosyn-
thetic pathways were previously known to
intersect, this study revealed that they are
also coregulated. The authors suggested
that ISCA andC1orf69 deficiency impaired
heme synthesis in their zebrafish assay
by activating (IRP1) and repressing ALA
synthesis.
To pursue identification of a possible
heme intermediate transporter or regula-
tory protein, they more intensively studied
SLC25A39, a member of the solute carrier
(SLC) family of mitochondrial membrane
proteins that transport a diverse array of
molecules, ranging from inorganic ions
to organic molecules such as citrate
and amino acid intermediates (Palmieri,
2008). They established that knockdown
of SLC25A39 reduced heme synthesis
and iron incorporation into heme but did
not cause accumulation of late intermedi-
ates of the heme biosynthetic pathway,
thus eliminating ferrochelatase deficiency
as a cause of the heme biosynthetic
failure. They performed genetic comple-
mentation studies and established that
human and mouse SLC25A39 are the
orthologs of yeast MTM1, a previously
characterized yeast solute carrier protein.
Although specific roles are known for
many SLCs, the role of MTM1, originally
believed to have a role in manganese
transport, remains unknown. More recent
phenotypic characterizations in yeast
suggested that MTM1 may affect the
Fe-S cluster biogenesis pathway because
MTM1 deficiency resulted in misincorpo-
ration of Fe into manganese SOD, similar
to a phenotype described for several
other proteins defective in yeast Fe-S
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PreviewsFigure 1. Intersections between the Fe-S Cluster and Heme Biosynthetic Pathways in
Erythroid Cells and Proposed Regulation of Mitochondrial Iron Homeostasis
In erythroid cells of mammals and zebrafish, defects in iron-sulfur cluster biogenesis proteins have been
observed to result in mitochondrial iron overload and cytosolic iron depletion. Loss of mitochondrial Fe-S
cluster biogenesis and cytosolic iron depletion can result in activation of iron regulatory proteins 1 and 2
(IRPs) to bind to iron-responsive elements (IREs), which are RNA stem-loop elements that are found in tran-
scripts of some ironmetabolismgenes.When IRPs bind to transcripts such as ALAS2 that contain an IRE in
the50UTR (shownasastem-loop in theALAS2mRNA), theyareexpected to repress translationanddiminish
ALAS2protein levels. ALAS2 encodes the first hemebiosynthetic enzyme, and the repressive role of the IRE
in zebrafish heme biosynthesis was detected in genetic rescue experiments in animals deficient in the Fe-S
cluster biogenesis protein, glutaredoxin 5 (data not shown). IRP-dependent repressionof ALAS2 translation
may account for the repression of heme synthesis in many experimental settings, including some of the
morpholino studies described by Nilsson et al. (2009) in this issue of Cell Metabolism. SLC25A39 and
ABCB7 are mitochondrial membrane transporters with unknown substrates that could participate in regu-
lation of mitochondrial iron homeostasis or transport of heme intermediates. In yeast, malfunction of the
SLC25A39 ortholog, MTM1, results in misdirection of iron into the active site of the mitochondrial manga-
nese superoxide dismutase, MnSOD, and increased oxidative stress. Misincorporation of iron into the
MnSOD has been observed in several yeast strains that have defective iron-sulfur cluster biogenesis,
and themisincorporationmaybecausedbyoverloadof aparticular typeofbioavailable iron inmitochondria.cluster biogenesis. Loss-of-MTM1activity
appears to facilitate generation of a form
of mitochondrial iron that can occupy
the manganese-binding site of Mn SOD
and exclude manganese binding, thereby
inactivatingmitochondrial superoxide dis-
mutase (Naranuntarat et al., 2009).
Thus, SLC25A39/MTM1 joins the ranks
of mitochondrial membrane proteins
whose functions in iron metabolism are
incompletely characterized, including
ABCB7 and its yeast homolog, Atm1
(Lill and Muhlenhoff, 2008). A possible
reason that the transported species of
SLC25A39 and ABCB7 remain uncharac-
terized could be that these proteins
transport regulatory molecules, ratherthan basic components of metabolism.
Numerous studies in yeast andmammalian
cells point to the conclusion that interrup-
tion of Fe-S cluster biogenesis results
inmitochondrial ironoverload (Lill andMuh-
lenhoff, 2008; Rouault and Tong, 2008). In
addition, human ALAS2 mutations result
in sideroblastic anemia, a type of anemia
that is characterized by mitochondrial iron
overload in developing erythroid cells (Ca-
maschella, 2008), suggesting that loss of
hemeoraheme intermediate canalsodrive
mitochondrial iron overload under some
circumstances. Moreover, recent data
show that a state of cytosolic iron depletion
can coexist with a state of mitochondrial
iron overload in mammalian cells thatCell Metabolismhave disruptions of the Fe-S cluster
machinery, suggesting that iron homeo-
stasis is regulated by distinct processes in
the cytosolic and mitochondrial compart-
ments (Rouault and Tong, 2008).
Although much more needs to be
discovered about how mitochondrial iron
homeostasis is regulated, it is possible
that export of a molecule that contains an
intact Fe-S cluster and/or a heme interme-
diate from mitochondria might be used to
convey the signal that mitochondria have
sufficient iron. Then, if either heme
synthesis or Fe-S cluster synthesis was
disrupted, the cytosolic/nuclear compart-
ment would perceive mitochondrial iron
deficiency and might respond by signifi-
cantly increasingmitochondrial iron stores.
As is shown Figure 1, defects in Fe-S
cluster biogenesis proteins, ABCB7, and
SLC25A39 can decrease heme synthesis,
and repression of ALAS2 translation may
be the common underlying mechanism.
Although the fundamental heme biosyn-
thetic enzymes were identified long ago,
this newwork illustrates thatmuch remains
to be discovered about the relationships
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